These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 12941612)

  • 1. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Takahashi Y; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Int J Oncol; 2003 Aug; 23(2):325-31. PubMed ID: 12851681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
    Hashimoto Y; Shimada Y; Itami A; Ito T; Kawamura J; Kawabe A; Kaganoi J; Maeda M; Watanabe G; Imamura M
    Eur J Cancer; 2003 Oct; 39(15):2239-46. PubMed ID: 14522385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.
    Toyota M; Miyazaki Y; Kitamura S; Nagasawa Y; Kiyohara T; Shinomura Y; Matsuzawa Y
    Life Sci; 2002 Feb; 70(13):1565-75. PubMed ID: 11895107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
    Mehta RG; Williamson E; Patel MK; Koeffler HP
    J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
    Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.
    Asou H; Verbeek W; Williamson E; Elstner E; Kubota T; Kamada N; Koeffler HP
    Int J Oncol; 1999 Nov; 15(5):1027-31. PubMed ID: 10536188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
    Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
    Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
    Itami A; Watanabe G; Shimada Y; Hashimoto Y; Kawamura J; Kato M; Hosotani R; Imamura M
    Int J Cancer; 2001 Nov; 94(3):370-6. PubMed ID: 11745416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
    Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M
    Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes.
    Nagase I; Yoshida S; Canas X; Irie Y; Kimura K; Yoshida T; Saito M
    FEBS Lett; 1999 Nov; 461(3):319-22. PubMed ID: 10567719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand.
    Kanbe E; Abe A; Towatari M; Kawabe T; Saito H; Emi N
    Exp Hematol; 2003 Apr; 31(4):300-8. PubMed ID: 12691917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
    Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
    Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
    Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
    He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
    Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.